Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peggy N Atmodimedjo

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Virchows Archiv : an International Journal of Pathology|August 16, 2015
Mitochondrial D310 mutation as clonal marker for solid tumorsWillemina R R Geurts-Giele, Gerard H G K Gathier, Peggy N Atmodimedjo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case SeriesSara G Creemers, Esther Korpershoek, Peggy N Atmodimedjo, et al.
Frontiers in Oncology|August 9, 2020
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype GlioblastomaFatih Incekara, Marion Smits, Sebastian R van der Voort, et al.
The Journal of Molecular Diagnostics : JMD|July 28, 2016
Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of GliomasHendrikus J Dubbink, Peggy N Atmodimedjo, Ronald van Marion, et al.
Acta Neuropathologica Communications|November 25, 2018
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsNathalie E Synhaeve, Martin J van den Bent, Pim J French, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Frontiers in Oncology|June 2, 2020
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter MethylationFatih Incekara, Sebastian R van der Voort, Hendrikus J Dubbink, et al.
Molecular Oncology|February 15, 2020
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplificationMieke R Van Bockstal, Marie Colombe Agahozo, Ronald van Marion, et al.
Neuro-Oncology|September 11, 2015
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trialHendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Virchows Archiv : an International Journal of Pathology|August 16, 2015
Mitochondrial D310 mutation as clonal marker for solid tumorsWillemina R R Geurts-Giele, Gerard H G K Gathier, Peggy N Atmodimedjo, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2017
Identification of Mutations in Cell-Free Circulating Tumor DNA in Adrenocortical Carcinoma: A Case SeriesSara G Creemers, Esther Korpershoek, Peggy N Atmodimedjo, et al.
Frontiers in Oncology|August 9, 2020
The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype GlioblastomaFatih Incekara, Marion Smits, Sebastian R van der Voort, et al.
The Journal of Molecular Diagnostics : JMD|July 28, 2016
Diagnostic Detection of Allelic Losses and Imbalances by Next-Generation Sequencing: 1p/19q Co-Deletion Analysis of GliomasHendrikus J Dubbink, Peggy N Atmodimedjo, Ronald van Marion, et al.
Acta Neuropathologica Communications|November 25, 2018
Clinical evaluation of a dedicated next generation sequencing panel for routine glioma diagnosticsNathalie E Synhaeve, Martin J van den Bent, Pim J French, et al.
European Journal of Medical Genetics|January 11, 2020
Development of esophageal squamous cell cancer in patients with FAMMM syndrome: Two clinical reportsBerend J van der Wilk, Bo J Noordman, Peggy N Atmodimedjo, et al.
Annals of Translational Medicine|September 17, 2021
Liquid biopsy in esophageal cancer: a case report of false-positive circulating tumor DNA detection due to clonal hematopoiesisJonathan Spoor, Ben M Eyck, Peggy N Atmodimedjo, et al.
Frontiers in Oncology|June 2, 2020
Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter MethylationFatih Incekara, Sebastian R van der Voort, Hendrikus J Dubbink, et al.
Molecular Oncology|February 15, 2020
Somatic mutations and copy number variations in breast cancers with heterogeneous HER2 amplificationMieke R Van Bockstal, Marie Colombe Agahozo, Ronald van Marion, et al.
Neuro-Oncology|September 11, 2015
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trialHendrikus J Dubbink, Peggy N Atmodimedjo, Johan M Kros, et al.
Pageof 3